GlassScriptPhysician profile
Joseph B Thibodeau
NPI 1316973381
$75,075.50
in general payments reported to CMS, 2019-2025
48 companies · $3,383 in 2025
The $3,383 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $16K · 2021: $13K · 2022: $2,337 · 2023: $9,402 · 2024: $4,841 · 2025: $3,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,175 · Travel and Lodging: $962 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,419.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,175.00 |
| Travel and Lodging | $961.69 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $32,253.45 | 2019-2025 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $23,424.29 | 2019-2025 | |
| Medtronic, INC. | $4,854.42 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Symplicity G3 |
| Medtronic Vascular, INC. | $3,377.85 | 2019-2020 | |
| Boston Scientific Corporation | $1,319.13 | 2019-2025 | General - Atherectomy, Rotablator Rotational Atherectomy System Console Kit, Rotapro |
| Pfizer INC. | $1,225.86 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,125.94 | 2019-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $1,026.81 | 2023-2025 | Evoque, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $989.71 | 2021-2025 | Navitor, Mitraclip, Amplatzer Amulet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $868.51 | 2019-2025 | Jardiance |
| Amgen INC. | $540.68 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $418.86 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $397.29 | 2021-2024 | Nexletol |
| Siemens Medical Solutions USA, INC. | $341.09 | 2024 | |
| Zoll Respicardia, INC. | $293.48 | 2021-2024 | Remede System |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $275.13 | 2019-2024 | (5044) Mcot |
| Janssen Pharmaceuticals, INC | $230.89 | 2019-2024 | Xarelto |
| Atricure, INC. | $197.06 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Amarin Pharma, INC. | $186.74 | 2019-2022 | |
| Novo Nordisk INC | $179.45 | 2024-2025 | Wegovy, Ozempic |
| Daxor Corporation | $170.34 | 2024-2025 | Bva-100 |
| Heartflow, INC. | $155.43 | 2023-2024 | Ffrct |
| Sanofi-Aventis U.S. LLC | $141.32 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $129.80 | 2019-2023 | Lifevest |
| Bridgebio Pharma, INC. | $129.17 | 2025 | Attruby |
| Lundbeck LLC | $122.32 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $113.29 | 2022-2023 | Optimizer |
| Merck Sharp & Dohme LLC | $111.36 | 2021-2024 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $46.93 | 2019 | |
| Chiesi USA, INC. | $46.74 | 2019 | |
| Abiomed | $42.12 | 2024 | Impella |
| Scpharmaceuticals INC. | $39.40 | 2024-2025 | |
| Cardiva Medical, INC. | $36.38 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Actelion Pharmaceuticals US, INC. | $33.65 | 2021-2023 | Uptravi, Opsumit |
| Biosense Webster, INC. | $30.30 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $30.00 | 2023-2024 | Inpefa |
| Cardiovascular Systems INC. | $24.13 | 2019 | |
| Teleflex LLC | $24.08 | 2025 | Guideliner |
| Alnylam Pharmaceuticals INC. | $23.51 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $20.18 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $19.19 | 2023 | Definity |
| Kowa Pharmaceuticals America, INC. | $18.11 | 2021 | |
| Baxter Healthcare | $14.78 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Vifor Pharma, INC. | $14.17 | 2019 | |
| Cvrx, INC. | $12.16 | 2023 | Barostim Neo System |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Thibodeau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.